The type V intermediate filament
lamins are the principal components of the nuclear matrix, including the nuclear lamina.
Lamins are divided into A-type and B-type, which are encoded by three genes, LMNA, LMNB1, and LMNB2. The alternative splicing of LMNA produces two major A-type
lamins,
lamin A and
lamin C. Previous studies have suggested that
lamins are involved in
cancer development and progression. A-type
lamins have been proposed as
biomarkers for
cancer diagnosis, prognosis, and/or follow-up. The aim of the present study was to investigate
lamins in
cancer cells from metastatic
pleural effusions using immunofluorescence, western blotting, and flow cytometry. In a sub-group of
lung adenocarcinomas, we found reduced expression of
lamin A but not of
lamin C. The reduction in
lamin A expression was correlated with the loss of
epithelial membrane antigen (EMA)/MUC-1, an epithelial marker that is involved in the epithelial to mesenchymal transition (EMT). Finally, the
lamin A expression was inversely correlated with the number of metastatic sites and the WHO Performance status, and association of pleural, bone and lung metastatic localizations was more frequent when
lamin A expression was reduced. In conclusion, low
lamin A but not
lamin C expression in pleural metastatic cells could represent a major actor in the development of
metastasis, associated with EMT and could account for a pejorative factor correlated with a poor Performance status.